MORE►
Ben Lamm
The bluebuck became extinct just 34 years after it was first scientifically documented. [Image: Colossal]
Colossal Targets Extinct Antelope—and Adds a New Branch to its De-Extinction ‘Tree of Life’
by Quincy Preston | Apr 30, 2026
At a $10 billion valuation—and spinning out new ventures—Colossal names the bluebuck its sixth de-extinction target, extending its biotech platform into antelope conservation through a global BioVault effort.
by David Seeley |
Feb 3, 2026
"We're losing species at an alarming rate, and the world urgently needs a distributed network of global BioVaults—a true backup plan for life on Earth," said Ben Lamm, Colossal BioSciences' co-founder and CEO.
MORE►
by Quincy Preston |
Dec 17, 2025
Dallas-based Colossal Biosciences’ nonprofit arm has doubled its funding to $100 million and released its first Impact Report as it puts technology to work from Yellowstone to the Texas Gulf Coast—and beyond.
MORE►
by Lance Murray |
Nov 13, 2025
The Bolson tortoise is North America's largest and rarest tortoise species. Its population has grown from 23 adults to over 800 individuals through captive breeding, with over 150 juveniles released since 2021 showing 80%+ survival rates.
MORE►
Cloned by Viagen in 2023 from cells frozen for more than 40 years, “Ollie,” a Przewalski’s horse foal shown here at five days old, marks another milestone in using biotechnology to help restore threatened animal populations. [Photo: Elizabeth Arellano Photography/Viagen]
Dallas Decacorn Colossal Buys Viagen, a Texas Pioneer in Animal Cloning
by Quincy Preston | Nov 4, 2025
The de-extinction startup is adding more than two decades of commercial cloning expertise to its portfolio with its first acquisition.
Days before the announcement, CEO Ben Lamm laid out his playbook at Venture Dallas 2025: run toward critics, treat promises to middle-America classrooms as seriously as commitments to investors—and spin out businesses worth more than $100 million.
MORE►
by Venture Dallas |
Oct 23, 2025
Top executives at Nasdaq and Susser Bank celebrated high-growth potential companies contributing to region’s rise in entrepreneurship and innovation
sponsored by Venture Dallas
MORE►
by David Seeley |
Sep 17, 2025
Dallas-based Colossal Biosciences announced an add-on Series C raise that values it at $10.32 billion. Meanwhile, eggs are being laid in Texas to help advance the "de-extinction" of the famously extinct dodo bird—with a little help from the Nicobar pigeon, the dodo's closest living relative.
MORE►
by Lance Murray |
Aug 26, 2025
Set for Oct. 30 at the George W. Bush Presidential Center, this year's Venture Dallas conference will assemble more than 500 entrepreneurs, investors, and business leaders for a day of transformative ideas and connections.
MORE►
![The South Island giant moa towered over New Zealand's forests for millions of years before becoming extinct within a century of Polynesian settlement around 1400 CE. Colossal Biosciences plans to resurrect the 500-pound birds using ancient DNA extracted from cave deposits and artificial egg technology. [Source image: Colossal Biosciences]](https://s24806.pcdn.co/wp-content/uploads/2025/07/Colossal-Moa-940x436.jpg)
The South Island giant moa towered over New Zealand's forests for millions of years before becoming extinct within a century of Polynesian settlement around 1400 CE. Colossal Biosciences plans to resurrect the 500-pound birds using ancient DNA extracted from cave deposits and artificial egg technology. [Source image: Colossal Biosciences]
Colossal Biosciences Takes On De‑Extinction of New Zealand’s 12‑Foot Moa After Dire Wolf Milestone
by Quincy Preston | Jul 9, 2025
The Dallas decacorn is scaling its de-extinction pipeline with indigenous leadership, a New Zealand subsidiary, and economic models for species preservation, including ecotourism opportunities. Filmmaker Sir Peter Jackson helped connect the collaborators, Colossal CEO Ben Lamm says.
MORE►
by Quincy Preston |
Jun 26, 2025
While TIME put Maximum Effort and Waymo on its 2025 worldwide covers, Dallas future-shaping companies are in the mix. Two are Dallas-based. Another Texas company—now a $2B brand—got its start here, too.
MORE►
by Quincy Preston |
Jun 5, 2025
In one of his first deep interviews since Colossal's dire wolf debut made global noise, Ben Lamm joins the TechStuff podcast to talk mammoths, backlash, and why he's not here to play it safe.
MORE►
by Glenn Hunter |
Apr 30, 2025
Dallas Innovates, in partnership with the Dallas Regional Chamber, once again is recognizing the most innovative leaders in AI in Dallas-Fort Worth. From visionaries and mavericks to transformers and academics, AI 75's class of 2025 are the AI pacesetters you need to know now.
MORE►
The Colossal Woolly Mice. [Photo: Business Wire]
Meet the Colossal Woolly Mouse, Created by Dallas-Based ‘Decacorn’ Colossal Biosciences
by David Seeley | Mar 4, 2025
Before Colossal Biosciences can "de-extinct" the woolly mammoth, some small steps are in order. They've now been taken by the Colossal Woolly Mouse—a gene-edited creation with "dramatically altered coat color, texture, and thickness reminiscent of the woolly mammoth’s core phenotypes."
MORE►
by Quincy Preston and David Seeley |
Jan 21, 2025
D CEO and Dallas Innovates' Innovation Award winners are working to resurrect extinct species, launching autonomous trucks, reinventing military aircraft, and bringing AI into the physical world—and that's just the beginning. The 2025 awards showcase game-changing achievements—including Texas' first newly minted decacorn—across 17 categories of innovation. Here’s a look at the innovators leading the way.
MORE►
by Quincy Preston |
Jan 15, 2025
Best known for its moonshot mission to revive the woolly mammoth, Colossal Biosciences has secured $200 million in Series C funding led by TWG Global. The world's first de-extinction company, founded in 2021 by entrepreneur Ben Lamm and renowned Harvard geneticist George Church, Colossal Biosciences is working to restore Earth's lost biodiversity, "making science fiction into science fact."
MORE►
by Lance Murray |
Jan 14, 2025
The funding will support groundbreaking research into artificial womb technologies with the goal of protecting endangered species and advancing wildlife conservation efforts, the foundation said.
MORE►
